Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Huazhuo Formula is a Traditional Chinese Medicine (TCM) herbal composition developed by Xiyuan Hospital of the China Academy of Chinese Medical Sciences. It is specifically indicated for the treatment of mild to moderate Alzheimer's disease in patients presenting with the 'Kidney Deficiency and Phlegm Obstruction' syndrome pattern. The formula is intended to improve cognitive performance and daily functioning by tonifying kidney essence and clearing pathological phlegm, which are central to the TCM understanding of dementia. It is currently being studied in clinical trials to evaluate its efficacy and safety profile relative to established performance goals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Huazhuo Formula (Xiyuan Hospital).